ClinConnect ClinConnect Logo
Search / Trial NCT06893588

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

Launched by VESALIO · Mar 24, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Vasospasm

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥22
  • 2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
  • 3. Vessel dilation procedure was performed with the NeVa VS
  • 4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure
  • Exclusion Criteria:
  • None

About Vesalio

Vesalio is a pioneering medical device company dedicated to advancing vascular health through innovative technologies. Specializing in the development of cutting-edge neurovascular solutions, Vesalio focuses on enhancing the treatment of complex conditions such as stroke and aneurysms. With a commitment to clinical excellence and patient safety, the company collaborates with leading healthcare professionals to conduct rigorous clinical trials that validate the efficacy and safety of its products. By integrating advanced engineering and clinical insights, Vesalio aims to improve patient outcomes and set new standards in the field of vascular intervention.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported